
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT
- About


SWK Holdings Corp (SWKH)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/16/2025: SWKH (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $18.5
1 Year Target Price $18.5
0 | Strong Buy |
1 | Buy |
0 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -14.96% | Avg. Invested days 50 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 177.35M USD | Price to earnings Ratio 10.35 | 1Y Target Price 18.5 |
Price to earnings Ratio 10.35 | 1Y Target Price 18.5 | ||
Volume (30-day avg) 1 | Beta 0.2 | 52 Weeks Range 11.99 - 16.23 | Updated Date 09/16/2025 |
52 Weeks Range 11.99 - 16.23 | Updated Date 09/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.41 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 46.55% | Operating Margin (TTM) 56.9% |
Management Effectiveness
Return on Assets (TTM) 5.74% | Return on Equity (TTM) 6.58% |
Valuation
Trailing PE 10.35 | Forward PE - | Enterprise Value 201861804 | Price to Sales(TTM) 4.74 |
Enterprise Value 201861804 | Price to Sales(TTM) 4.74 | ||
Enterprise Value to Revenue 4.52 | Enterprise Value to EBITDA 7.03 | Shares Outstanding 12147400 | Shares Floating 2318087 |
Shares Outstanding 12147400 | Shares Floating 2318087 | ||
Percent Insiders 6.44 | Percent Institutions 87.36 |
Upturn AI SWOT
SWK Holdings Corp

Company Overview
History and Background
SWK Holdings Corp. was founded in 2010. It focuses on providing specialized financing solutions to companies in the healthcare sector. The company has grown through strategic investments and portfolio expansions in various healthcare verticals.
Core Business Areas
- Healthcare Finance: Provides financing solutions to healthcare companies, including specialty finance, venture debt, and asset-based lending.
Leadership and Structure
Winston Black serves as CEO. The company has a board of directors and operates with a structured management team focusing on investment and portfolio management.
Top Products and Market Share
Key Offerings
- Specialty Finance: Offers customized financing solutions to healthcare companies. Market share data is not readily available as this is a niche market; competitors include other specialty finance firms focused on healthcare. Revenue from this product varies year to year. Competitors: Oxford Finance, Silicon Valley Bank (now part of First Citizens), Hercules Capital.
Market Dynamics
Industry Overview
The healthcare finance industry is driven by innovation and growth, requiring significant capital for research, development, and commercialization. Specialty finance caters to the needs of companies that may not qualify for traditional bank loans.
Positioning
SWK Holdings Corp is positioned as a specialized finance provider in the healthcare sector, focusing on companies with unique financial needs. Their competitive advantage lies in their expertise and tailored solutions.
Total Addressable Market (TAM)
The TAM for healthcare specialty finance is estimated to be in the billions. SWK Holdings Corp is positioned to capture a portion of this market through targeted lending and investment strategies.
Upturn SWOT Analysis
Strengths
- Specialized expertise in healthcare finance
- Customized financing solutions
- Experienced management team
- Strong portfolio of investments
Weaknesses
- Concentration in the healthcare sector
- Reliance on economic conditions affecting healthcare companies
- Small cap status
Opportunities
- Expansion into new healthcare verticals
- Strategic partnerships with healthcare organizations
- Increased demand for specialized healthcare finance
Threats
- Changes in healthcare regulations
- Increased competition from other finance providers
- Economic downturn affecting healthcare investments
Competitors and Market Share
Key Competitors
- OXSQ
- AINV
- ARCC
Competitive Landscape
SWK Holdings Corp competes with other specialty finance firms in the healthcare sector. Their competitive advantage lies in their expertise, tailored solutions, and focus on specific healthcare verticals.
Major Acquisitions
Enteris BioPharma
- Year: 2019
- Acquisition Price (USD millions): 47.5
- Strategic Rationale: Acquisition of royalty rights which are now managed by SWK's royalty monetization investment portfolio.
Growth Trajectory and Initiatives
Historical Growth: SWK Holdings Corp's historical growth can be assessed by examining its revenue and earnings growth over the past few years.
Future Projections: Future growth projections can be obtained from analyst estimates available on financial websites.
Recent Initiatives: Recent initiatives may include new investment strategies, partnerships, or expansions into new markets.
Summary
SWK Holdings is a niche player in healthcare finance with specialized expertise. The company's tailored financing solutions provide a competitive edge. Success depends on navigating healthcare regulations and adapting to market conditions. Growing competition and economic factors affecting healthcare are threats to watch.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Yahoo Finance
- Bloomberg
Disclaimers:
This analysis is based on available information and should not be considered investment advice. Financial data and market conditions are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About SWK Holdings Corp
Exchange NASDAQ | Headquaters Dallas, TX, United States | ||
IPO Launch date 1999-09-22 | CEO & President Mr. Jody. D Staggs | ||
Sector Financial Services | Industry Asset Management | Full time employees 29 | Website https://www.swkhold.com |
Full time employees 29 | Website https://www.swkhold.com |
SWK Holdings Corporation is a venture debt firm specializing in early stage, seed/startup, series-A to series-D and growth capital investments. It seeks to invest in healthcare sectors including biopharma, medical devices, diagnostics, life science tools, selective healthcare service and HIT companies; technology; software; SaaS; and green energy/sustainability. It seeks to make investments between $5 million and $20 million, it may also invest higher. SWK Holdings Corporation was incorporated in 1996 and is headquartered in Dallas, Texas.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.